World's first inactivated Sabin polio vaccine approved by China FDA

China's FDA has awarded marketing approval of the world's first Sabin strain inactivated polio vaccine, marking a milestone as well for the Institute of Medical Biology of the Academy of Medical Sciences.

The institute independently developed the strain but tapped the assistance of the World Health Organization (WHO), the U.S. Centers for Disease Control and Prevention (CDC), Japan's National Institute of Infectious Diseases (NIID), the European Medicines Agency (EMA) and the U.K. in the review process, CFDA said.

China intends to provide the vaccine to developing countries through WHO's polio eradication program.

- here's the announcement from the CFDA (in Chinese)

Suggested Articles

An online pharmacy has again criticized FDA action after tipping off regulators to the existence of a dangerous impurity in Zantac and other antacids.

A group of senators is asking the FTC to take a careful look at pharma mergers given the cost of drugs in the U.S.

Life’s been tough for J&J's prostate cancer med Erleada in its battle with Pfizer-Astellas’ Xtandi. A new FDA nod could help level the playing field.…